Influenza or something else
A new syndromic testing device, the QIAstat-Dx is cutting costs and saving time in the emergency room.
Patients are often brought into emergency rooms with a number of symptoms which don’t allow for a clear diagnoses. Providing the wrong treatment is both costly and could result in dangerous side effects. But what if there was a way to determine a specific virus or bacteria with a simple syndromic test?
“With QIAstat-Dx we get the results virtually upon the patient’s arrival at the hospital,” says Visseaux. Moreover, “it has also led to some unexpected insights. It used to be, for instance, that the respiratory syncytial virus was thought to be the cause of severe respiratory illness only in children. Such on-the-spot testing has now shown that it lies at the root of many severe infections in adults as well.”
The impressive little system also reduces the quantity of medications prescribed. “It changed our perception, our prescription habits, and it will change the way we work in the future,” says Dr. Celestin Alexis Agbessi, Visseaux’s colleague, while cleaning his classes. Agbessi is convinced that if you change prescription habits and how you think about the patient, you save money, see fewer side effects, use less antibiotics and save time. “In the end,” says Agbessi, “we gain money for both the community and the patients. That is really a big step forward.”
Testing millions to stop tuberculosisDr. Eskild Petersen consults in Oman to spearhead the fight against the world's deadliest infectious disease.
Tuberculosis diagnosis turns patients into advocatesOver a decade ago, the Halsteads returned from their honeymoon with an infection known to kill 1.5 million people a year globally and learned how to overcome the disease.
Analyzing the ancient origins of rare genetic diseasesEsteemed geneticist, Dr. Bisgin, uses QIAGEN bioinformatic tools to help find a cure for rare genetic diseases in Turkey.